You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
Thor Medical comments on the Telix agreement
Text:
Hanna Norrlid | [email protected]
Norwegian radiopharma pioneer Thor Medical has signed a five-year supply agreement with Australian Telix Pharmaceuticals for thorium-228, a key precursor for Pb-212 in next-generation targeted alpha therapies. The agreement underlines the value of the production facility...